Transpek Industry Ltd

Transpek Industry Ltd

₹ 1,854 0.18%
19 Apr - close price
About

Incorporated in 1965, Transpek Industry Limited is into the manufacturing and export of a range of chemicals servicing the requirements of customers from a diverse range of industries including Textiles, Pharmaceuticals, Agrochemicals, Advanced Polymers, etc. [1]

Key Points

Product Portfolio
Co. manufactures chlorinated products used as intermediates and specialty chemicals for applications in Specialty Chemicals, Surfactants, Agrochemicals, Dyes, Polymers, and Pharma. [1]

  • Market Cap 1,035 Cr.
  • Current Price 1,854
  • High / Low 2,287 / 1,615
  • Stock P/E 18.7
  • Book Value 1,102
  • Dividend Yield 1.48 %
  • ROCE 19.9 %
  • ROE 16.0 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 18.5%
  • Company's working capital requirements have reduced from 75.5 days to 60.4 days

Cons

  • Company has a low return on equity of 13.3% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
91 96 122 155 180 143 211 216 196 203 162 121 148
77 79 104 124 149 126 182 181 154 163 140 108 121
Operating Profit 14 18 18 31 31 16 30 35 42 40 23 13 28
OPM % 16% 18% 15% 20% 17% 11% 14% 16% 21% 20% 14% 11% 19%
5 5 10 4 11 4 4 4 4 5 12 4 5
Interest 3 2 2 3 3 3 4 5 5 6 4 3 4
Depreciation 7 8 7 7 8 8 8 8 8 8 9 9 9
Profit before tax 9 12 19 24 31 10 22 27 33 31 21 6 20
Tax % 11% 11% 28% 28% 27% -16% 26% 25% 25% 28% 25% 46% 29%
8 11 14 18 23 11 16 20 25 22 16 3 14
EPS in Rs 14.36 19.59 24.21 31.51 41.14 20.25 29.36 35.79 44.26 40.05 28.38 5.35 25.21
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
184 242 269 290 284 317 361 595 566 339 599 827 634
184 216 242 251 236 263 314 478 447 292 499 676 530
Operating Profit 0 26 27 38 48 53 47 117 118 47 100 151 104
OPM % 0% 11% 10% 13% 17% 17% 13% 20% 21% 14% 17% 18% 16%
4 4 8 11 2 7 10 18 17 17 24 14 26
Interest 13 14 14 13 11 9 12 19 16 10 11 19 17
Depreciation 9 8 9 9 8 9 10 14 26 29 30 33 35
Profit before tax -18 8 12 27 32 42 35 101 94 26 84 113 78
Tax % 12% 9% 38% 18% 33% 29% 25% 35% 22% 9% 22% 26%
-16 7 8 22 21 30 26 66 73 23 65 83 55
EPS in Rs -26.98 12.52 12.82 37.41 36.24 53.67 47.26 117.70 130.59 41.73 117.09 149.46 98.99
Dividend Payout % 0% 24% 19% 13% 21% 17% 19% 17% 10% 18% 19% 18%
Compounded Sales Growth
10 Years: 13%
5 Years: 18%
3 Years: 13%
TTM: -17%
Compounded Profit Growth
10 Years: 28%
5 Years: 26%
3 Years: 5%
TTM: -24%
Stock Price CAGR
10 Years: 29%
5 Years: 3%
3 Years: 12%
1 Year: 5%
Return on Equity
10 Years: 17%
5 Years: 16%
3 Years: 13%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 39 45 50 69 85 200 241 306 333 374 479 581 610
105 104 101 77 64 88 203 144 116 111 137 145 72
63 65 87 77 55 93 116 143 134 109 143 155 203
Total Liabilities 213 219 244 229 209 386 566 599 589 599 764 887 891
112 113 106 92 94 117 179 236 287 287 295 365 381
CWIP 1 2 5 5 10 13 56 33 19 14 16 24 23
Investments 4 4 4 5 5 131 144 149 118 142 196 238 271
96 101 129 126 100 125 188 180 166 156 258 260 216
Total Assets 213 219 244 229 209 386 566 599 589 599 764 887 891

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
22 20 26 19 44 47 7 128 111 35 47 111
-6 -5 -9 14 -16 -31 -103 -45 -33 -17 -70 -13
-16 -14 -17 -33 -27 -17 96 -83 -77 -3 9 -94
Net Cash Flow -0 1 -0 -0 1 -1 0 -0 0 15 -14 4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 91 83 100 103 59 78 94 57 58 82 60 52
Inventory Days 123 90 89 68 111 91 87 68 70 82 77 54
Days Payable 146 123 146 114 60 83 103 72 73 81 65 45
Cash Conversion Cycle 68 50 43 57 110 85 78 54 54 83 72 61
Working Capital Days 30 25 21 64 61 62 88 42 60 91 75 60
ROCE % -4% 14% 17% 22% 28% 23% 13% 27% 24% 7% 18% 20%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
58.35% 57.48% 57.48% 57.48% 57.48% 57.49% 57.49% 57.47% 57.47% 57.47% 57.47% 57.47%
1.83% 1.83% 1.83% 1.83% 1.85% 1.85% 1.85% 1.80% 1.85% 1.86% 0.95% 0.05%
2.24% 2.42% 2.29% 2.11% 2.09% 2.00% 1.99% 1.79% 1.79% 1.79% 1.79% 1.79%
0.71% 0.71% 0.71% 0.74% 0.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
36.87% 37.56% 37.69% 37.84% 37.84% 38.68% 38.68% 38.95% 38.89% 38.88% 39.78% 40.69%
No. of Shareholders 13,36312,83613,86713,75913,79413,77213,57113,45312,93513,30813,41114,669

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls